We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SLNH:NASDAQSoluna Holdings, Inc. Analysis

Data as of 2026-07-28 - not real-time

$1.23

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Soluna Holdings trades at $1.23, comfortably below its 20‑day ($1.255), 50‑day ($1.51) and 200‑day ($1.562) simple moving averages, underscoring a clear bearish price trend. The 14‑day RSI sits at 44.9, indicating neutral momentum but edging toward oversold territory, while the MACD histogram turned positive, delivering a bullish signal despite the overall downtrend. Volatility is extreme, with a 30‑day swing of 112% and a beta north of 4.5, exposing the stock to outsized market moves. Fundamentally, the company posted a 58% revenue surge and a robust 65% gross margin, yet operating and net margins remain negative, with EBITDA and free cash flow deeply in the red. A solid cash pile of $68.6 M offsets $27.9 M of debt, but operating cash flow is still negative, and ROE/ROA are deeply depressed. Analysts’ consensus is a “strong buy” with a median target of $4, implying a potential 225% upside, while market sentiment is in “Extreme Greed” mode.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below all major SMAs indicating bearish bias
  • Bullish MACD histogram suggests a possible short‑term bounce
  • Decreasing volume and extreme volatility raise execution risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 58% year‑over‑year revenue growth and strong gross margins
  • Cash balance exceeds debt, providing a financial cushion
  • Analyst target of $4 represents >200% upside potential

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term demand for cryptocurrency mining and high‑performance computing
  • Substantial cash reserves to fund future expansion or weather downturns
  • Regulatory environment remains a wildcard but could be mitigated by diversification

Key Metrics & Analysis

Financial Health

Revenue Growth58.30%
Profit Margin-190.87%
P/E Ratio-4.6
ROE-95.56%
ROA-19.22%
Debt/Equity24.48
P/B Ratio2.8
Op. Cash Flow$-15344000
Free Cash Flow$-34616500
Industry P/E18.0

Technical Analysis

TrendBearish
RSI44.9
Support$1.03
Resistance$1.46
MA 20$1.25
MA 50$1.51
MA 200$1.56
MACDBullish
VolumeDecreasing
Fear & Greed Index88.09

Valuation

Target Price$4.00
Upside/Downside225.20%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta4.49
Volatility112.22%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.